Plaque psoriasis drug Tremfya receives Australian & Brazilian approvals
MorphoSys AG, a late-stage, biopharmaceutical company, announced that country subsidiaries of its licensee Janssen reported that Tremfya (guselkumab) has been approved for... Read More